A A financial report card on the company, Oramed Pharmaceuticals (symbol ORMP) (15 Marks) www.soc.gov Assume that in 2021, the company is now in production of an insulin pill and that its product inventory is progressively becoming more expensive over the next 3 years, thereafter (10.. 4 years on), it is expected that costs will be falling consistently. It is expected that the company will be able to sell most of its inventory for a sizeable profit over the next few year In addition, in an effort to ramp up production of its insulin pill , it is acquiring additional plant capacity at a cost of $10,000,000. The plant will be ready for use July 1, 2021 and last 10 year with no residual at the end of its life. Oramed Pharmaceuticals is under pressure by shareholders to increase profits in the calander year of 2021 and 2022. Given the context of your answer in Part A, explain and quantity, where possible, what you would do, as CFO, of the company (10 Marks) A A financial report card on the company, Oramed Pharmaceuticals (symbol ORMP) (15 Marks) www.soc.gov Assume that in 2021, the company is now in production of an insulin pill and that its product inventory is progressively becoming more expensive over the next 3 years, thereafter (10.. 4 years on), it is expected that costs will be falling consistently. It is expected that the company will be able to sell most of its inventory for a sizeable profit over the next few year In addition, in an effort to ramp up production of its insulin pill , it is acquiring additional plant capacity at a cost of $10,000,000. The plant will be ready for use July 1, 2021 and last 10 year with no residual at the end of its life. Oramed Pharmaceuticals is under pressure by shareholders to increase profits in the calander year of 2021 and 2022. Given the context of your answer in Part A, explain and quantity, where possible, what you would do, as CFO, of the company (10 Marks)